House com­mit­tee de­bates IRA changes that would im­pact or­phan drugs and oth­er ar­eas

US law­mak­ers in the House of Rep­re­sen­ta­tives are look­ing at mul­ti­ple bills that would make changes to the In­fla­tion Re­duc­tion Act, in­clud­ing how Medicare price ne­go­ti­a­tions are im­ple­ment­ed and which drugs are el­i­gi­ble for ex­emp­tions.

In a three-hour hear­ing by the House Com­mit­tee on En­er­gy and Com­merce on Thurs­day, rep­re­sen­ta­tives were par­tic­u­lar­ly fo­cused on the bi­par­ti­san Op­ti­miz­ing Re­search Progress Hope And New (OR­PHAN) Cures Act and Main­tain­ing In­vest­ments in New In­no­va­tion (MI­NI) Act.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER